Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 6/20 | 0.58 |
| ▸ | CCND1 | P24385 | 6/20 | 0.58 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.54 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.54 |
| ▸ | CDK1 | P06493 | 1/20 | 0.54 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.54 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.54 |
| ▸ | CDK2 | P24941 | 1/20 | 0.54 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 3/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.53 |
| ▸ | PARP14 | Q460N5 | 9/20 | 0.52 |
| ▸ | KIF11 | P52732 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL4637697 | 0.92 | CDK4 (0.56) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL29407801 | 0.91 | KIF11 (0.57) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL1326376 | 0.91 | KIF11 (0.57) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL208888 | 0.91 | KIF11 (0.57) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL30641449 | 0.91 | KIF11 (0.57) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL38828 | 0.91 | KIF11 (0.57) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL1326378 | 0.89 | KIF11 (0.55) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL30985273 | 0.87 | CDK4 (0.54) | CDK4CCND1CCNB2CCNE2CDK1 | |
| SCHEMBL866841 | 0.87 | KIF11 (0.53) | CDK4CCND1PARP14KIF11 | |
| SCHEMBL30985274 | 0.87 | CDK4 (0.54) | CDK4CCND1CCNB2CCNE2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116891585-A | Preparation method of soluble polyaryletherketone film with low toxicity solvent | 大连中科聚合新材料科技有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-116790006-A | Preparation method of polyarylethersulfone film with low toxicity solvent | 大连中科聚合新材料科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-110655642-B | Carbazolyl-containing quaternary phosphonium salt and metalloporphyrin polymer microporous material as well as preparation method and application thereof | 海南大学 | 2022-07-08 | — | — | CN | claimed |
| CN-110655642-A | Carbazolyl-containing quaternary phosphonium salt and metalloporphyrin polymer microporous material and preparation method and application thereof | 海南大学 | 2020-01-07 | — | — | CN | claimed |
| EP-2448925-B1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORP (JP) | 2017-12-06 | — | — | EP | claimed |
| US-8927121-B2 | Emissive aryl-heteroaryl compounds | NITTO DENKO CORPORATION (JP) | 2015-01-06 | — | — | US | claimed |
| CN-104016996-A | Novel benzopyran photo-chromic derivative | SHANGHAI GANTIAN OPTICAL MATERIAL CO LTD | 2014-09-03 | — | — | CN | claimed |
| US-8771845-B2 | — | — | 2014-07-08 | — | — | US | claimed |
| US-20130284907-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2013-10-31 | — | — | US | claimed |
| US-20100326526-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2010-12-30 | — | — | US | claimed |
| EP-3609867-B1 | CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF | GSNO THERAPEUTICS INC (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-110372540-B | 3, 6-di (prop-2-ylidene) cyclohexa-1, 4-diene derivatives, methods of making, uses, and devices | 武汉尚赛光电科技有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-110655642-B | Carbazolyl-containing quaternary phosphonium salt and metalloporphyrin polymer microporous material as well as preparation method and application thereof | 海南大学 | 2022-07-08 | — | — | CN | disclosed |
| CN-111290216-B | Hard mask composition, hard mask and method for forming pattern | 厦门恒坤新材料科技股份有限公司 | 2022-05-20 | — | — | CN | disclosed |
| CN-111240153-B | Hard mask composition, hard mask and method for forming pattern | 厦门恒坤新材料科技股份有限公司 | 2022-05-20 | — | — | CN | disclosed |
| WO-2003091262-A1 | BRIDGED BI-AROMATIC LIGANDS, COMPLEXES, CATALYSTS AND PROCESSES FOR POLYMERIZING AND POYMERS THEREFROM | SYMYX TECHNOLOGIES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-6451455-B1 | CHARGE CARRIER LAYER COMPRISES A COMPOUND HAVING TWO 2-METHYL-8-QUINOLINOLATO LIGANDS COORDINATED WITH AL AS ELECTRON TRANSPORTING MOIETIES AND ONE TRIARYLAMINE DERIVATIZED PHENOXIDE AS A HOLE TRANSPORTING MOIETY | THE TRUSTEES OF PRINCETON UNIVERSITY | 2002-09-17 | — | — | US | disclosed |
| EP-1044586-A4 | HIGHLY TRANSPARENT NON-METALLIC CATHODES | UNIV PRINCETON (US) | 2000-11-08 | — | — | EP | disclosed |
| EP-1044586-A2 | HIGHLY TRANSPARENT NON-METALLIC CATHODES | The Trustees of Princeton University (US) | 2000-10-18 | — | — | EP | disclosed |
| WO-1999020081-A2 | HIGHLY TRANSPARENT NON-METALLIC CATHODES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1999-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100326526-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | AHR, AR, ARNT | CDK4 489/4885CCND1 1090/4885CCNB2 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.